NKGen Biotech Activates New Clinical Trial Sites in Canada and Florida for Alzheimer’s Disease Treatment Study
23/6 14:13
NKGen Biotech activates two new clinical trial sites for Alzheimer's treatment, enhancing patient access and recruitment for troculeucel therapy....